180 related articles for article (PubMed ID: 15273662)
1. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
Chorna I; Bilyy R; Datsyuk L; Stoika R
Exp Oncol; 2004 Jun; 26(2):111-7. PubMed ID: 15273662
[TBL] [Abstract][Full Text] [Related]
2. Expression of mRNA coding for TGF-beta and its receptors in irradiated human breast carcinoma MCF-7 cells differing in their sensitivity to doxorubicin.
Chorna I; Fedorenko O; Datsyuk L; Stoika R
Exp Oncol; 2005 Jun; 27(2):156-8. PubMed ID: 15995636
[TBL] [Abstract][Full Text] [Related]
3. Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma.
Stoika RS; Yakymovych IA; Kashchak NI; Boyko MM; Korynevska AV; Klyuchyvska OY; Shafranska GI; Yakymovych MY; Zhylchuk VY; Kudryavets YY; Vorontsova AL
Exp Oncol; 2008 Mar; 30(1):35-41. PubMed ID: 18438339
[TBL] [Abstract][Full Text] [Related]
4. Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives.
Chorna IV; Datsyuk LO; Stoika RS
Exp Oncol; 2005 Sep; 27(3):196-201. PubMed ID: 16244580
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
6. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitizing activity of caffeic acid in multidrug-resistant MCF-7/Dox human breast carcinoma cells.
Ahn CH; Choi WC; Kong JY
Anticancer Res; 1997; 17(3C):1913-7. PubMed ID: 9216644
[TBL] [Abstract][Full Text] [Related]
8. Molecular profile and cell cycle in MCF-7 and MCF-7/Dox cells exposed to conventional and liposomal forms of doxorubicin.
Rusetskaya NV; Lukyanova NY; Chekhun VF
Exp Oncol; 2009 Sep; 31(3):140-3. PubMed ID: 19783968
[TBL] [Abstract][Full Text] [Related]
9. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
10. Normal p53 status and function despite the development of drug resistance in human breast cancer cells.
Wosikowski K; Regis JT; Robey RW; Alvarez M; Buters JT; Gudas JM; Bates SE
Cell Growth Differ; 1995 Nov; 6(11):1395-403. PubMed ID: 8562478
[TBL] [Abstract][Full Text] [Related]
11. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
Toi M; Bicknell R; Harris AL
Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
[TBL] [Abstract][Full Text] [Related]
13. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
14. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
15. A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.
Seth P; Katayose D; Li Z; Kim M; Wersto R; Craig C; Shanmugam N; Ohri E; Mudahar B; Rakkar AN; Kodali P; Cowan K
Cancer Gene Ther; 1997; 4(6):383-90. PubMed ID: 9408609
[TBL] [Abstract][Full Text] [Related]
16. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
17. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by AN-152, a cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), in LHRH-R positive human breast cancer cells is independent of multidrug resistance-1 (MDR-1) system.
Günthert AR; Gründker C; Bongertz T; Nagy A; Schally AV; Emons G
Breast Cancer Res Treat; 2004 Oct; 87(3):255-64. PubMed ID: 15528968
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
Danforth DN; Sgagias MK
Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of apoptosis induced by SIRT1 deacetylase inhibitors in human breast cancer MCF-7 drug-resistant cells].
Li Y; Xu R; Zhang XM; Li DD; He QY
Yao Xue Xue Bao; 2008 Oct; 43(10):1003-10. PubMed ID: 19127863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
